OGEN

Oragenics

0.20

0.01+2.77%

After Hours: 0.2049 +0.0049 +2.45%19:59 05/16 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.2000/0.1946

TODAY RANGE0.1908-0.2011

VOL387.89K

MARKET CAP4.30M

52 WEEK RANGE0.1617-3.430

AVG VOL (3M)398.87K

% TURNOVER1.81%

TURNOVER--

P/E (TTM)-0.1253

% RANGE5.09%

EPS(TTM)-1.5959

P/E(FORWARD)0.0167

P/B-11.8343

BVPS-0.0169

DIVIDEND--

P/S16.39

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.09M

SHARES OUTSTANDING21.48M

NEXT EARNINGS08/07-08/11

FREE FLOAT20.44M

LOT SIZE1

EX-DIV DATE01/23/2023

News

Press Releases

Financial Reports

Profile

Benzinga·3d ago
Oragenics Receives Approval From HREC In Australia To Initiate Phase II Clinical Trial Evaluating ONP-002 For Treatment Of mTBI
Benzinga·05/05 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·05/02 20:56
Oragenics Appoints Janet Huffman as CEO and CFO
TipRanks·04/09 13:06
Oragenics announces HDEC submission for Phase II concussion trial
Benzinga·04/07 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga·04/02 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga·03/27 12:38
Oragenics Provides Q1 2025 Update Highlighting Strategic Progress In Concussion Treatment, Advancements In ONP-002, Partnership With BRAINBox Solutions, $5M Fundraising, And Key Regulatory And Clinical Milestones
TipRanks·03/06 14:35
Oragenics submits IB for Phase II clinical trial of ONP-002 in mTBI
TipRanks·02/25 14:03
Oragenics CMO to present at Emergencies in Medicine Conference
Dow Jones·02/24 13:30
Press Release: Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
TipRanks·02/11 13:41
Oragenics announces partnership with BRAINBox Solutions
TipRanks·02/07 16:15
Biotech Alert: Searches spiking for these stocks today
Benzinga·02/05 14:44
US Stocks Mixed; Walt Disney Posts Upbeat Earnings
Benzinga·02/05 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Dow Jones·02/04 21:16
*Oragenics Withdraws Filing for a Securities Offering

Same Industry

Name/Symbol

Change%

Price

Oragenics

OGEN

+2.77%

0.2000

Regeneron Pharmaceuticals

REGN

+1.59%

594.32

Entero Therapeutics

ENTO

-1.33%

0.4243

BIONTECH

BNTX

+0.47%

92.77

United Therapeutics Corp.

UTHR

+0.47%

305.35

Vertex Pharmaceuticals Inc

VRTX

+0.98%

438.65

Siga Technologie

SIGA

+1.18%

5.99

Moderna

MRNA

+5.12%

24.86

Charles Riv Labs Intl Inc

CRL

+1.50%

140.97

Medpace Holdings

MEDP

+3.12%

305.66

Talphera Inc

TLPH

+2.86%

0.5040

ICON PLC

ICLR

+0.74%

131.63

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

+1.70%

142.82

MOLECULAR PARTNERS AG

MOLN

-0.26%

3.84

Arcturus Therape

ARCT

+0.09%

11.65

Gilead Sciences Inc

GILD

+2.15%

102.50

PRA Health

PRAH

165.21

Incyte Corp

INCY

+0.88%

63.31

Aptevo Therapeutics Inc

APVO

-3.03%

0.3200

Biospecifics

BSTC

+0.15%

88.53